Sucralfate Suspension
Product Images NDC 50268-745

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 50268-745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (50268 745 11)

The text seems to be a partial label of a medication called "Sucralfate Oral Suspension" with a strength of 1g/10mL. The label also gives instructions to shake the bottle before use and has some alphanumeric codes that may be related to the manufacturing or distribution of the product. It is unclear whether this medication is intended for veterinary or human use.*

FDA Label Image

40 (745 14)

Sucralfate is an oral suspension medication available in a container of 40 units with each unit measuring 10mL. The recommended adult dosage is 1g (2 teaspoons) to be taken four times a day on an empty stomach. The exact medication details and instructions can be found on the package insert. The medication should be stored at room temperature between 20°C-25°C (66°F-77°F) and delivered in a controlled room temperature environment. Sucralfate oral suspension is manufactured by AKARE and should be shaken well before use; it should also be avoided from freezing.*

FDA Label Image

Chemical Structure (Sucralfate Oral Suspension 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.